ARTICLE | Company News
Endo, ProStrakan sales and marketing update
August 31, 2009 7:00 AM UTC
Endo received exclusive, U.S. rights to commercialize ProStrakan's Fortigel testosterone. In May, ProStakan submitted a complete response to FDA for Fortigel to treat male hypogonadism. ProStrakan wi...